Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2010-01-04 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-LOUIS (68300), Haut-Rhin
PHARMACIE DE BOURGFELDEN : revenue, balance sheet and financial ratios
PHARMACIE DE BOURGFELDEN is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-LOUIS (68300),
this company of category PME
shows in 2019 a revenue of 2.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE BOURGFELDEN (SIREN 518877295)
Indicator
2023
2021
2019
2018
2017
2016
Revenue
N/C
N/C
2 042 970 €
N/C
1 825 564 €
1 883 423 €
Net income
36 425 €
61 878 €
98 971 €
123 800 €
100 635 €
112 382 €
EBITDA
N/C
N/C
138 727 €
N/C
120 428 €
169 706 €
Net margin
N/C
N/C
4.8%
N/C
5.5%
6.0%
Revenue and income statement
In 2023, PHARMACIE DE BOURGFELDEN generates positive net income of 36 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 112 k€ -> 36 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
36 425 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 86%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
86.328%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.245%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE BOURGFELDEN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2023
Debt ratio
252.348
196.734
150.75
118.679
112.339
86.328
Financial autonomy
24.34
28.774
36.05
40.722
42.58
48.245
Repayment capacity
11.052
13.674
None
8.926
None
None
Cash flow / Revenue
6.244%
4.852%
None%
5.34%
None%
None%
Sector positioning
Debt ratio
86.332023
2019
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of PHARMACIE DE BOURGFELDEN (86.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.24%2023
2019
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of PHARMACIE DE BOURGFELDEN (48.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
8.93 years2019
2019
Q1: 1.73 years
Med: 5.0 years
Q3: 9.49 years
Average
In 2019, the repayment capacity of PHARMACIE DE BOURGFELDEN (8.93) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 131.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
131.657
Liquidity indicators evolution PHARMACIE DE BOURGFELDEN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2021
2023
Liquidity ratio
98.621
92.453
102.799
89.642
178.345
131.657
Interest coverage
17.431
15.585
None
10.528
None
None
Sector positioning
Liquidity ratio
131.662023
2019
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch+5 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE BOURGFELDEN (131.66) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
10.53x2019
2019
Q1: 1.36x
Med: 5.4x
Q3: 11.35x
Good
In 2019, the interest coverage of PHARMACIE DE BOURGFELDEN (10.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 193 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 824 days. Excellent situation: suppliers finance 631 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
193 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
824 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE BOURGFELDEN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2023
Operating WCR
131 689 €
154 424 €
0 €
167 789 €
0 €
0 €
Inventory turnover (days)
26
26
0
28
0
0
Customer payment term (days)
5
5
130
6
124
193
Supplier payment term (days)
62
67
912
41
784
824
Positioning of PHARMACIE DE BOURGFELDEN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE BOURGFELDEN is estimated at
429 795 €
(range 261 379€ - 604 196€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
261k€429k€604k€
429 795 €Range: 261 379€ - 604 196€
NAF 5 année 2023
Valuation method used
Net Income Multiple
36 425 €
×
11.8x
=429 796 €
Range: 261 379€ - 604 197€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE BOURGFELDEN with other companies in the same sector:
Frequently asked questions about PHARMACIE DE BOURGFELDEN
What is the revenue of PHARMACIE DE BOURGFELDEN ?
The revenue of PHARMACIE DE BOURGFELDEN in 2019 is 2.0 M€.
Is PHARMACIE DE BOURGFELDEN profitable?
Yes, PHARMACIE DE BOURGFELDEN generated a net profit of 36 k€ in 2023.
Where is the headquarters of PHARMACIE DE BOURGFELDEN ?
The headquarters of PHARMACIE DE BOURGFELDEN is located in SAINT-LOUIS (68300), in the department Haut-Rhin.
Where to find the tax return of PHARMACIE DE BOURGFELDEN ?
The tax return of PHARMACIE DE BOURGFELDEN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE BOURGFELDEN operate?
PHARMACIE DE BOURGFELDEN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart